Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 6:33 pm Purchase | 2025-09-30 | 13G | Pelthos Therapeutics Inc. PTHS | Ikarian Capital, LLC | 186,408 6.100% | 186,408 (New Position) | Filing History |
| 2025-11-14 1:52 pm Purchase | 2025-09-30 | 13G | Pelthos Therapeutics Inc. PTHS | Murchinson Ltd. | 280,000 9.100% | 280,000 (New Position) | Filing History |
| 2025-11-10 4:42 pm Purchase | 2025-11-06 | 13D | Pelthos Therapeutics Inc. PTHS | LIGAND PHARMACEUTICALS INC LGND | 5,189,177 49.900% | 261,309 (+5.30%) | Filing History |
| 2025-08-13 6:24 pm Unchanged | 2025-06-30 | 13G | Pelthos Therapeutics Inc. PTHS | AME Equities LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-07-08 4:05 pm Purchase | 2025-07-01 | 13G | Pelthos Therapeutics Inc. PTHS | 3i, LP | 303,138 9.900% | 303,138 (New Position) | Filing History |
| 2025-07-03 9:07 pm Purchase | 2025-07-01 | 13D | Pelthos Therapeutics Inc. PTHS | Friedberg Ezra M | 250,121 8.300% | 250,121 (New Position) | Filing History |
| 2025-07-03 4:05 pm Purchase | 2025-07-01 | 13D | Pelthos Therapeutics Inc. PTHS | LIGAND PHARMACEUTICALS INC LGND | 4,927,868 49.900% | 4,927,868 (New Position) | Filing History |
| 2025-02-14 1:09 pm Purchase | 2024-12-31 | 13G | Channel Therapeutics Corporation CHRO | Ikarian Capital, LLC | 44,085 7.300% | 44,085 (New Position) | Filing History |
| 2025-01-15 5:27 pm Purchase | 2024-12-13 | 13G | Channel Therapeutics Corporation CHRO | Alexandra Wood (Canada) Inc. | 57,419 9.530% | 57,419 (New Position) | Filing History |
| 2024-11-13 4:05 pm Sale | 2024-09-30 | 13G | Channel Therapeutics Corporation CHRO | 3i, LP | 30,100 4.990% | -1,782 (-5.59%) | Filing History |
| 2024-03-04 4:07 pm Purchase | 2024-02-21 | 13G | Channel Therapeutics Corporation CHRO | Boswell Prayer Ltd. | 47,159 8.200% | 47,159 (New Position) | Filing History |
| 2024-03-01 5:19 pm Purchase | 2024-02-21 | 13G | Channel Therapeutics Corporation CHRO | Benuvia Operations LLC | 38,423 6.700% | 38,423 (New Position) | Filing History |
| 2024-03-01 5:16 pm Purchase | 2024-02-21 | 13G | Channel Therapeutics Corporation CHRO | Aperture Healthcare Ventures Ltd. | 44,407 7.700% | 44,407 (New Position) | Filing History |
| 2024-03-01 5:13 pm Purchase | 2024-02-21 | 13G | Channel Therapeutics Corporation CHRO | AME Equities LLC | 36,918 6.400% | 36,918 (New Position) | Filing History |
| 2024-03-01 5:10 pm Purchase | 2024-02-21 | 13G | Channel Therapeutics Corporation CHRO | Motif Pharmaceuticals Ltd. | 48,341 8.400% | 48,341 (New Position) | Filing History |
| 2024-03-01 5:07 pm Purchase | 2024-02-21 | 13G | Channel Therapeutics Corporation CHRO | 3i, LP | 31,882 5.500% | 31,882 (New Position) | Filing History |
| 2024-02-26 6:36 pm Purchase | 2024-02-15 | 13D | Channel Therapeutics Corporation CHRO | Friedberg Ezra M | 54,572 9.500% | 54,572 (New Position) | Filing History |